We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
378 hedge funds and large institutions have $12.4B invested in Madrigal Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 130 increasing their positions, 129 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
96% more call options, than puts
Call options by funds: $397M | Put options by funds: $203M
1% more repeat investments, than reductions
Existing positions increased: 130 | Existing positions reduced: 129
0.14% less ownership
Funds ownership: 103.78% → 103.63% (-0.14%)
2% less first-time investments, than exits
New positions opened: 62 | Existing positions closed: 63
2% less funds holding
Funds holding: 387 → 378 (-9)
9% less capital invested
Capital invested by funds: $13.7B → $12.4B (-$1.28B)
38% less funds holding in top 10
Funds holding in top 10: 13 → 8 (-5)
Holders
378
Holders Change
-9
Holders Change %
-2.33%
% of All Funds
4.66%
Holding in Top 10
8
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-38.46%
% of All Funds
0.1%
New
62
Increased
130
Reduced
129
Closed
63
Calls
$397M
Puts
$203M
Net Calls
+$195M
Net Calls Change
+$142M
Top Buyers
Top Sellers
| 1 |
PC
Paulson & Co
New York
|
-$151M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$108M |
| 3 |
Alkeon Capital Management
New York
|
-$76.4M |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$56.4M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$44.9M |
